Clinical trials: Dysfunctional Central Venous Access Devices (CVADS)

Dysfunctional Central Venous Access Devices (CVADS)

Cathflo Activase Pediatric Study

• Completed
• Age: Up to 17 years
• Phase 4

This was a Phase IV, open-label, single-arm, multicenter trial that was to be conducted at ~60 sites in the United States. Approximately 300 pediatric subjects with dysfunctional CVADs (including catheters with valves, multiple…

Trial name

NCT00307580

Testing

Cathflo Activase (Alteplase)

Volunteers

300 people

Sponsor

Genentech, Inc.